Regional cerebral metabolic rate (positron emission tomography) during inhalation of nitrous oxide 50% in humans. 2008

P Reinstrup, and E Ryding, and T Ohlsson, and A Sandell, and K Erlandsson, and K Ljunggren, and L G Salford, and S Strand, and T Uski
Department of Anaesthesiology and Intensive Care, University Hospital, S22185 Lund, Sweden. peter.reinstrup@med.lu.se

BACKGROUND Recent studies in man have shown that cerebral blood flow increases during inhalation of nitrous oxide (N2O), a finding which is believed to be a result of an increased cerebral metabolic rate (CMR). However, this has not previously been evaluated in man. METHODS Regional CMR(glu) (rCMR(glu)) was measured three dimensionally with positron emission tomography (PET) after injection of 2-(18F)fluoro-2-deoxy-D-glucose in 10 spontaneously breathing men (mean age 31 yr) inhaling either N2O 50% in O2 30% or O2 30% in N2. RESULTS Global CMR(glu) in young men was 27 (3) micromol 100 g(-1) min(-1) [mean (SD)]. Inhalation of N2O 50% did not change global CMR(glu) [30 (5) micromol 100 g(-1) min(-1)] significantly, but it changed the distribution of the metabolism in the brain (P<0.0001 analysis of variance). Compared with inhalation of O2 30% in N2, N2O 50% inhalation increased the metabolism in the basal ganglia [14 (17)%, P<0.05] and thalamus [22 (23) %, P<0.05]. There was a prolonged metabolic effect of N2O inhalation seen on a succeeding PET scan with oxygen-enriched air (P<0.0001) performed 1 h after the N2O administration. CONCLUSIONS Inhalation of N2O 50% did not change global CMR(glu), but the metabolism increased in central brain structures, an effect that was still present 1 h after discontinuation of N2O.

UI MeSH Term Description Entries
D008297 Male Males
D009609 Nitrous Oxide Nitrogen oxide (N2O). A colorless, odorless gas that is used as an anesthetic and analgesic. High concentrations cause a narcotic effect and may replace oxygen, causing death by asphyxia. It is also used as a food aerosol in the preparation of whipping cream. Laughing Gas,Nitrogen Protoxide,Gas, Laughing,Oxide, Nitrous
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002560 Cerebrovascular Circulation The circulation of blood through the BLOOD VESSELS of the BRAIN. Brain Blood Flow,Regional Cerebral Blood Flow,Cerebral Blood Flow,Cerebral Circulation,Cerebral Perfusion Pressure,Circulation, Cerebrovascular,Blood Flow, Brain,Blood Flow, Cerebral,Brain Blood Flows,Cerebral Blood Flows,Cerebral Circulations,Cerebral Perfusion Pressures,Circulation, Cerebral,Flow, Brain Blood,Flow, Cerebral Blood,Perfusion Pressure, Cerebral,Pressure, Cerebral Perfusion
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D049268 Positron-Emission Tomography An imaging technique using compounds labelled with short-lived positron-emitting radionuclides (such as carbon-11, nitrogen-13, oxygen-15 and fluorine-18) to measure cell metabolism. It has been useful in study of soft tissues such as CANCER; CARDIOVASCULAR SYSTEM; and brain. SINGLE-PHOTON EMISSION-COMPUTED TOMOGRAPHY is closely related to positron emission tomography, but uses isotopes with longer half-lives and resolution is lower. PET Imaging,PET Scan,Positron-Emission Tomography Imaging,Tomography, Positron-Emission,Imaging, PET,Imaging, Positron-Emission Tomography,PET Imagings,PET Scans,Positron Emission Tomography,Positron Emission Tomography Imaging,Positron-Emission Tomography Imagings,Scan, PET,Tomography Imaging, Positron-Emission,Tomography, Positron Emission
D018685 Anesthetics, Inhalation Gases or volatile liquids that vary in the rate at which they induce anesthesia; potency; the degree of circulation, respiratory, or neuromuscular depression they produce; and analgesic effects. Inhalation anesthetics have advantages over intravenous agents in that the depth of anesthesia can be changed rapidly by altering the inhaled concentration. Because of their rapid elimination, any postoperative respiratory depression is of relatively short duration. (From AMA Drug Evaluations Annual, 1994, p173) Inhalation Anesthetic,Inhalation Anesthetics,Anesthetic Gases,Anesthetic, Inhalation,Gases, Anesthetic
D019275 Radiopharmaceuticals Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) Radiopharmaceutical
D019788 Fluorodeoxyglucose F18 The compound is given by intravenous injection to do POSITRON-EMISSION TOMOGRAPHY for the assessment of cerebral and myocardial glucose metabolism in various physiological or pathological states including stroke and myocardial ischemia. It is also employed for the detection of malignant tumors including those of the brain, liver, and thyroid gland. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1162) 18F Fluorodeoxyglucose,18FDG,2-Fluoro-2-deoxy-D-glucose,2-Fluoro-2-deoxyglucose,Fludeoxyglucose F 18,18F-FDG,Fluorine-18-fluorodeoxyglucose,Fluorodeoxyglucose F 18,2 Fluoro 2 deoxy D glucose,2 Fluoro 2 deoxyglucose,F 18, Fludeoxyglucose,F 18, Fluorodeoxyglucose,F18, Fluorodeoxyglucose,Fluorine 18 fluorodeoxyglucose,Fluorodeoxyglucose, 18F

Related Publications

P Reinstrup, and E Ryding, and T Ohlsson, and A Sandell, and K Erlandsson, and K Ljunggren, and L G Salford, and S Strand, and T Uski
January 1989, Life sciences,
P Reinstrup, and E Ryding, and T Ohlsson, and A Sandell, and K Erlandsson, and K Ljunggren, and L G Salford, and S Strand, and T Uski
March 1997, Anesthesiology,
P Reinstrup, and E Ryding, and T Ohlsson, and A Sandell, and K Erlandsson, and K Ljunggren, and L G Salford, and S Strand, and T Uski
November 2006, Anesthesiology,
P Reinstrup, and E Ryding, and T Ohlsson, and A Sandell, and K Erlandsson, and K Ljunggren, and L G Salford, and S Strand, and T Uski
August 1996, Circulation,
P Reinstrup, and E Ryding, and T Ohlsson, and A Sandell, and K Erlandsson, and K Ljunggren, and L G Salford, and S Strand, and T Uski
January 2001, Clinical nuclear medicine,
P Reinstrup, and E Ryding, and T Ohlsson, and A Sandell, and K Erlandsson, and K Ljunggren, and L G Salford, and S Strand, and T Uski
April 1986, Journal of applied physiology (Bethesda, Md. : 1985),
P Reinstrup, and E Ryding, and T Ohlsson, and A Sandell, and K Erlandsson, and K Ljunggren, and L G Salford, and S Strand, and T Uski
August 1996, Circulation,
P Reinstrup, and E Ryding, and T Ohlsson, and A Sandell, and K Erlandsson, and K Ljunggren, and L G Salford, and S Strand, and T Uski
April 1991, Sleep,
P Reinstrup, and E Ryding, and T Ohlsson, and A Sandell, and K Erlandsson, and K Ljunggren, and L G Salford, and S Strand, and T Uski
May 2001, Anesthesiology,
P Reinstrup, and E Ryding, and T Ohlsson, and A Sandell, and K Erlandsson, and K Ljunggren, and L G Salford, and S Strand, and T Uski
January 1979, Transactions of the American Neurological Association,
Copied contents to your clipboard!